Guangzhou Fineimmune Biotechnology Co., Ltd.

This is an early-stage safety study testing a new type of personalized immune cell therapy for patients with advanced liver cancer. The therapy, called Super CAR-T, involves collecting a patient's own immune cells, modifying them in a lab to better target their cancer, and then i…

This is an early-stage safety study testing a new type of personalized cell therapy for patients with advanced solid tumors. Doctors will collect a patient's own immune cells, genetically modify them to better recognize a specific cancer marker called NY-ESO-1, and then infuse th…